Skip to main content

Advertisement

Advertisement

ADVERTISEMENT

Volume 16, Issue 8, August 2019 - First Report Managed Care

Featured Article

08/26/2019

Dean Celia

Dean Celia
The IRS, with input from HHS, expands list of preventive care options for HSA participants with high deductible health plans; our experts offer insights, predict the level of adoption, and address potential downsides.
The IRS, with input from HHS, expands list of preventive care options for HSA participants with high deductible health plans; our experts offer insights, predict the level of adoption, and address potential downsides.
The IRS, with input from HHS,...
08/26/2019
First Report Managed Care
08/26/2019

Mary Beth Nierengarten

Mary Beth Nierengarten
The June MEDPAC report outlines areas where improvement is needed, emphasizing the importance of Medicare beneficiaries’ access to primary care and increasing incentive for medical students to choose primary care as a career choice.
The June MEDPAC report outlines areas where improvement is needed, emphasizing the importance of Medicare beneficiaries’ access to primary care and increasing incentive for medical students to choose primary care as a career choice.
The June MEDPAC report outlines...
08/26/2019
First Report Managed Care
Formulary Frontlines®
08/26/2019

Eileen Koutnik-Fotopoulos

Eileen Koutnik-Fotopoulos
Although hemophilia is designated an orphan disease by the FDA because it affects fewer than 200,000 people in the United States, it imposes a significant financial and burden on patients, caregivers, and society.
Although hemophilia is designated an orphan disease by the FDA because it affects fewer than 200,000 people in the United States, it imposes a significant financial and burden on patients, caregivers, and society.
Although hemophilia is...
08/26/2019
First Report Managed Care

Department

Formulary Frontlines®
08/26/2019

Eileen Koutnik-Fotopoulos

Eileen Koutnik-Fotopoulos
Although hemophilia is designated an orphan disease by the FDA because it affects fewer than 200,000 people in the United States, it imposes a significant financial and burden on patients, caregivers, and society.
Although hemophilia is designated an orphan disease by the FDA because it affects fewer than 200,000 people in the United States, it imposes a significant financial and burden on patients, caregivers, and society.
Although hemophilia is...
08/26/2019
First Report Managed Care
Managed Care Q&A
08/26/2019

Edan Stanley

Edan Stanley
Scott Vogel, partner and PBM executive, Confidio, recently spoke about the many challenges biosimilars face coming to market and where the market might be heading.
Scott Vogel, partner and PBM executive, Confidio, recently spoke about the many challenges biosimilars face coming to market and where the market might be heading.
Scott Vogel, partner and PBM...
08/26/2019
First Report Managed Care
Managed Care Q&A
08/26/2019

Edan Stanley

Edan Stanley
Sonja Quale, PharmD, chief clinical officer and vice president of informatics, Confidio, recently spoke about the many challenges biosimilars face coming to market and where the market might be heading
Sonja Quale, PharmD, chief clinical officer and vice president of informatics, Confidio, recently spoke about the many challenges biosimilars face coming to market and where the market might be heading
Sonja Quale, PharmD, chief...
08/26/2019
First Report Managed Care
Conference Insider
08/26/2019

Edan Stanley

Edan Stanley
Gregory O Callahan, MBA, consultant, and Brian N Anderson, MBA, principal, both from Milliman, a consulting and actuarial firm, offer expertise on how to maximize the effectiveness of specialty contracts.
Gregory O Callahan, MBA, consultant, and Brian N Anderson, MBA, principal, both from Milliman, a consulting and actuarial firm, offer expertise on how to maximize the effectiveness of specialty contracts.
Gregory O Callahan, MBA,...
08/26/2019
First Report Managed Care
Conference Insider
08/26/2019

Edan Stanley

Edan Stanley
Susan Trieu, PharmD, director of enterprise specialty clinical solutions at MedImpact Health Systems, discusses new therapies in the pipeline and what payers should focus on.
Susan Trieu, PharmD, director of enterprise specialty clinical solutions at MedImpact Health Systems, discusses new therapies in the pipeline and what payers should focus on.
Susan Trieu, PharmD, director of...
08/26/2019
First Report Managed Care
News Connection
08/26/2019
The Centers for Medicare & Medicaid Services announced a plan to expand coverage for ambulatory blood pressure monitoring (ABPM) in response to a request from stakeholders.
The Centers for Medicare & Medicaid Services announced a plan to expand coverage for ambulatory blood pressure monitoring (ABPM) in response to a request from stakeholders.
The Centers for Medicare &...
08/26/2019
First Report Managed Care
News Connection
08/26/2019
In October 2018, the Trump administration proposed rule changes to the criteria immigration officials use to determine whether an immigrant becomes a public charge and a recent study shows that these changes could result in over 8 million...
In October 2018, the Trump administration proposed rule changes to the criteria immigration officials use to determine whether an immigrant becomes a public charge and a recent study shows that these changes could result in over 8 million...
In October 2018, the Trump...
08/26/2019
First Report Managed Care

Insights

Commentary
08/26/2019

Robin Lloyd, chief commercial officer, Health Fidelity

Robin Lloyd, chief commercial officer...
Robin Lloyd, chief commercial officer, Health Fidelity, discusses the latest trends and policy changes impacting ACOs and reflects on new federal policies, highlighting future opportunities in value-based care.
Robin Lloyd, chief commercial officer, Health Fidelity, discusses the latest trends and policy changes impacting ACOs and reflects on new federal policies, highlighting future opportunities in value-based care.
Robin Lloyd, chief commercial...
08/26/2019
First Report Managed Care

Advertisement

Advertisement

Advertisement